• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Myriad Genetics

Myriad Genetics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Global Pharmacogenomics Market 2014-2024: Advancement in Technology Pharmacogenomics Engineering to Create In-Vivo Environment - Research and Markets

    Global Pharmacogenomics Market 2014-2024: Advancement in Technology Pharmacogenomics Engineering to Create In-Vivo Environment - Research and Markets

  2. Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth Trends & Forecast to 2021 - Research and Markets

    Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth Trends & Forecast to 2021 - Research and Markets

  3. Worldwide IVD Market Procedure and Pricing Analysis 2016-2021 - Research and Markets

    Worldwide IVD Market Procedure and Pricing Analysis 2016-2021 - Research and Markets

  4. Global Breast Cancer Predictive Genetic Testing Market Outlook 2022 - Research and Markets

    Global Breast Cancer Predictive Genetic Testing Market Outlook 2022 - Research and Markets

  5. Emerging Molecular Diagnostic Technologies and Strategic Profiles of Leading Suppliers 2017 - Research and Markets

    Emerging Molecular Diagnostic Technologies and Strategic Profiles of Leading Suppliers 2017 - Research and Markets

  6. Medical Laboratory Testing Services Report 2017 - Medical Laboratory Testing Services Reaches 12 Billion Tests Per Year - Research and Markets

    Medical Laboratory Testing Services Report 2017 - Medical Laboratory Testing Services Reaches 12 Billion Tests Per Year - Research and Markets

  7. Global Medical Laboratory Testing Services Report 2017 - Europe Version - Detailed Breakouts for 15 Countries & 4 Regions - Research and Markets

    Global Medical Laboratory Testing Services Report 2017 - Europe Version - Detailed Breakouts for 15 Countries & 4 Regions - Research and Markets

  8. Global Next Generation Cancer Diagnostics Market to Grow 32.3% by 2022 - Anticipated to Reach $20.9 Billion - Research and Markets

    Global Next Generation Cancer Diagnostics Market to Grow 32.3% by 2022 - Anticipated to Reach $20.9 Billion - Research and Markets

  9. Global Emerging Cancer Diagnostics (Tumor Biomarker Test) Market Analysis & Forecast 2017-2023: Focus on Biomarker Test Type, Application & Market Trends - Research and Markets

    Global Emerging Cancer Diagnostics (Tumor Biomarker Test) Market Analysis & Forecast 2017-2023: Focus on Biomarker Test Type, Application & Market Trends - Research and Markets

12

©2017 Morningstar Advisor. All right reserved.